PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
66.13
-0.87 (-1.30%)
Mar 27, 2026, 4:00 PM EDT - Market closed
PTC Therapeutics Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$80.94
Upside
+22.40%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $90 → $92 | Buy | Maintains | $90 → $92 | +39.12% | Feb 23, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $93 → $86 | Buy | Maintains | $93 → $86 | +30.05% | Feb 20, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $87 → $82 | Hold | Maintains | $87 → $82 | +24.00% | Feb 20, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $97 → $93 | Strong Buy | Maintains | $97 → $93 | +40.63% | Feb 20, 2026 |
| Barclays | Barclays | Hold → Buy Upgrades $68 → $119 | Hold → Buy | Upgrades | $68 → $119 | +79.95% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $82 → $91 | Buy → Hold | Downgrades | $82 → $91 | +37.61% | Dec 1, 2025 |
| Barclays | Barclays | Hold Maintains $46 → $68 | Hold | Maintains | $46 → $68 | +2.83% | Nov 6, 2025 |
| Citigroup | Citigroup | Hold Maintains $50 → $75 | Hold | Maintains | $50 → $75 | +13.41% | Nov 5, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $50 → $63 | Hold | Maintains | $50 → $63 | -4.73% | Nov 5, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $70 → $82 | Buy | Maintains | $70 → $82 | +24.00% | Nov 5, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $44 → $50 | Strong Sell | Maintains | $44 → $50 | -24.39% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $73 → $93 | Buy | Maintains | $73 → $93 | +40.63% | Nov 5, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $63 → $77 | Strong Buy | Maintains | $63 → $77 | +16.44% | Oct 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +78.44% | Sep 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $79 → $73 | Buy | Maintains | $79 → $73 | +10.39% | Aug 20, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $76 → $71 | Buy | Maintains | $76 → $71 | +7.36% | Aug 20, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.